Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Micro-X Ltd. ( (AU:MX1) ) has shared an announcement.
Micro-X Limited reported a 155% surge in revenue to $10.1 million for the half-year to 31 December 2025, driven by growing sales of its X-ray technologies, while its net loss narrowed to $6.6 million, a 24% improvement on the prior corresponding period. The company’s adjusted loss, restated to exclude prior-year R&D cash rebates for comparability, fell by about 45%, but net tangible assets per share declined to 0.79 cents and auditors highlighted a material uncertainty over going concern, underlining that the business remains dependent on further revenue growth or funding to support its operations.
The most recent analyst rating on (AU:MX1) stock is a Sell with a A$0.07 price target. To see the full list of analyst forecasts on Micro-X Ltd. stock, see the AU:MX1 Stock Forecast page.
More about Micro-X Ltd.
Micro-X Limited is an Australian technology company focused on developing and commercialising advanced X-ray imaging systems. Its products target applications in medical diagnostics, security screening and defence, with a strategic emphasis on innovative, lightweight systems that can open niche global markets. The company remains in a growth and investment phase, relying on R&D and scaling revenues to reach sustainable profitability.
Average Trading Volume: 224,541
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$50.83M
For a thorough assessment of MX1 stock, go to TipRanks’ Stock Analysis page.